Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Sintilimab
Trade Name
Synonyms IBI308|Tyvyt
Drug Descriptions

Sintilimab (IBI308) is a monoclonal antibody that targets PD-1 (PDCD1), potentially resulting in enhanced anti-tumor immune response (PMID: 29300693, PMID: 29900038, PMID: 32656988).

DrugClasses Immune Checkpoint Inhibitor 94 PD-L1/PD-1 antibody 62

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Sintilimab Bevacizumab Sintilimab 0 0
Cisplatin + Fluorouracil + Sintilimab Cisplatin Fluorouracil Sintilimab 0 1
Cisplatin + Paclitaxel + Sintilimab Cisplatin Paclitaxel Sintilimab 0 1
Sintilimab Sintilimab 1 1


Additional content available in CKB BOOST